Northern United Pharmaceutical has changed its leadership, but it is not alarmed.

Originally, Beilian was a merger of several pharmaceutical companies, and the cadres went through the baptism of the party school, and those who could come back smoothly were all frightened birds, and they all obediently exerted their residual heat in their respective posts.

The workers themselves are very gossip about the changes at the top, but Qi Lezhang's wave of leaders is not close to the people, and Dong Ce and others who were replaced later are also low-key.

As a result, the workers only know that the leader has changed, and they don't even know what the replacement looks like.

The factory of more than 10,000 people is indeed larger.

In the past, the workers knew each other well, and some even worked in a workshop for three generations, which was not so much a national factory as a workers' back garden. Now that they have merged, although they are all factories that have heard each other's names, and some people may still have in-laws, but after all, they are separated by one layer, and everyone is not as happy as before.

Some subordinates who are used to working in state-owned enterprises and follow Dong Ce came to Dong Ce very worriedly at this time and said: "It is difficult to become a comrade with a piece of notice, Manager Dong has taken up his new position, let's make some big moves." ”

Dong Ce immediately sternly refused, and said: "Before the new drug is developed, everyone has to tighten the strings, and no matter how big the action is, the research and development of new drugs must be the first." ”

Somehow this conversation got out, and it was discussed among the workers.

A few days later, reporters from "Medical and Health News" and "Chemical Industry News" came to the door and did an interview.

As a result, the words of General Manager Dong Ce were circulated.

Maybe it's someone who is trying to help the trouble, or maybe it's natural growth, and after a few days of brewing, several magazines that may lock chapters with their names have also released in-depth interviews.

General Manager Dong Ce's fame rose all of a sudden.

"Research as the Direction of Enterprise"

Articles such as "Supporting and not interfering in technological development is our belief" suddenly became popular in the corporate world.

On the one hand, there is a Nobel Prize factor bonus, and on the other hand, it is completely unexpected social needs.

The question of how much power the factory director should have was discussed in depth in the corporate world in the 80s.

This is not something that can be said casually.

A factory, first of all, has a factory director and a secretary.

Listening to the director or the secretary means who is the leader for a factory.

In the military, the reform of the party's command of the gun can be described as of far-reaching significance.

The Soviets tried the factory director system and the secretary system very early, and China followed the one-factory system, that is, a thorough factory director responsibility system, but in 87 years, it was still very unclear who was responsible.

Hoping to find a good way and promote the idea of the whole country is even more hindering the directors and secretaries from taking charge of their own factories.

Dong Ce looked like he knew something, and he immediately attracted the attention of relevant industry insiders.

To put it simply, there are four types of people in China at this time, civil servants, staff of public institutions, farmers and workers of state-owned enterprises.

An event that can be followed by any type of person is not a small event, not to mention that it is still the peak stage of state-owned enterprise reform.

The research of the ion channel laboratory has also been pushed into the attention of everyone.

In just a few days, a reporter found Peking University, ambushed Yang Rui on the road, jumped out, took the cameraman, and quickly interviewed: "Mr. Yang Rui, I heard that you plan to use 30 million US dollars to develop a drug, is that so?"

No one needs to remind you, the camera with a red light also shows that the reporter is not easy to mess with.

Yang Rui didn't even need to ask to see his press card to know that the other party was a genuine reporter.

Ordinary fake reporters can't afford to rent a camera.

However, Yang Rui still asked: "Are you a reporter, can you show me your ID?"

With the time to break up, Yang Rui sorted out his thoughts.

Yang Rui is handsome, speaking with a smile, whether it is in the camera or in reality, he has a good image, and the request he puts forward makes the reporter unable to refuse.

The latter hesitated for a moment and showed his press card.

After Yang Rui saw it, he showed it in the lens of the camera, and said: "Thanks to reporter Li's concern, we do have a plan to develop new drugs, but the amount of $30 million is not accurate." ”

"It is said that your initial budget is $15 million, and the planned expenditure is $30 million, so what is the latest projection now?" reporter Li said, beckoning the camera forward with his left hand, ready to shoot a close-up of Yang Rui's face.

He has already stuck the minimum value above $15 million, no matter how much Yang Rui says, it is enough for him to be sarcastic.

Yang Rui smiled as if he couldn't see the camera, and said: "$30 million to develop a new drug is too little, at present, the average cost of developing a new drug in the world is about $200 million, which is seven $30 million." When it comes to a specific drug, the development cost is always $100 million. We haven't decided where to go yet, but $30 million is certainly not enough. ”

$30 million is actually enough for Yang Rui to develop a new drug. Others try a few more directions, and the cost will soar, but Yang Rui saves a lot of trouble.

However, Yang Rui cannot admit the cost of $30 million.

If he admits this cost now, how can he sell it at a high price in the future?

With the ability of domestic pharmaceutical companies, it is a fool's dream to pass an application such as the FDA. The Americans have a strict drug management system, the British, the French, and the Australian are not easy, and the Japanese and Koreans have their own routines.

Therefore, before there are large multinational pharmaceutical companies, it is difficult for Chinese to develop a new drug on their own.

That is, Yang Rui and the prestige of the Nobel Prize, all started from rare drugs.

This is his second case of new drug development.

However, $30 million was an extremely shocking figure for Chinese in the 80s.

The same is true for journalists.

Although reporter Li made a lot of preparations, he didn't expect that Yang Rui would say that $30 million was not enough.

It's just a medicine......

"A drug costs 30 million US dollars, will it be too much?" Reporter Li paused, as if he was worried that what he said was too thin, and added: "We are still a developing country, there are still many poor people in the country, and foreign exchange is even more scarce, will it be too wasteful to develop a drug." ”

"First of all, it's a drug that can save hundreds of thousands of people, if not millions. Second, the $30 million or more in development funding itself is provided by foreign companies. We can use this foreign investment to make a sum of money, which can not only be used for further scientific research, but also help the development of domestic enterprises, why not?" Yang Rui asked rhetorically, but the logic was one link after another.

The reporter was silent for a long time and said, "I see...... This is really a great thing for the benefit of the country and the people......"

Yang Rui was also silent for a moment, and said in his heart, he deserves to be a reporter.

Black news can't be done, are you ready to transform?

Yang Rui nodded heavily, and said: "We scientific research workers are facing fierce international competition, and we have to compete with world-class laboratories and pharmaceutical companies, but we can't get the same funding and equipment support, so we can only find our own ways to shorten the distance with our foreign counterparts as much as possible......"

"Professor Yang is working too hard, by the way, what kind of disease is this new drug used to treat?"

"We talked as we walked. On the way to the cafeteria, Yang Rui briefly introduced grape cerebroside.

Now that the interview has begun, it has to start and finish.

The reporter recorded it, and when he returned to Taiwan, the more he thought about it, the more unwilling he became, so he simply wrote an article first, titled: "Remembering the Birth of a Chinese Miracle Medicine".

Throughout the article, reporter Li focused on the bull of Yang Rui, the authority of the Nobel Prize, and the benefits of miracle medicine, but he never talked about the indications of miracle medicine.

At first glance, it seems that Yang Rui has made some elixir that can cure all diseases.

Monday.

As soon as Yang Rui arrived at the office, he didn't even drink a sip of tea, when he saw Hu Chi rushing in in a hurry, complaining: "You still come to work at some point, someone called me at 5 o'clock in the morning." ”

"Do what?"

"I want your miracle medicine, get it, come with me, the hospital is waiting, and I will see you get rid of the medicine. Hu Chi couldn't help but say, and pulled Yang Rui out of the door.

(End of chapter)